Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New turkish scale aims to measure thinking problems in Parkinson's

NCT ID NCT07253376

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Gazi University Source: ClinicalTrials.gov ↗

First seen Jan 06, 2026 · Last updated Jun 20, 2026 · Updated 30 times

Summary

This study translates a scale that measures how thinking difficulties affect daily life in people with Parkinson's disease into Turkish. Researchers will test the translated version in 60 Turkish-speaking Parkinson's patients to see if it is valid and reliable. The goal is to give doctors a better tool to assess cognitive function in this population.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Ankara Bilkent City Hospital, Physical Medicine and Rehabilitation Hospital

    Ankara, 06800, Turkey (Türkiye)

  • Gazi University, Faculty of Health Sciences

    Ankara, 06490, Turkey (Türkiye)

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could provide a reliable tool for Turkish-speaking clinicians to assess cognitive impacts in Parkinson's patients.

What could go wrong

This is a small, early-stage translation and validation study, not a treatment trial. The scale may not perform as well in broader populations.

Conditions

The condition(s) this trial relates to.

cognitive disorder Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.